Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer

NCT00806286 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Non-small Cell Lung Cancer

Interventions

DRUG: CS7017 tablets
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Placebo Tablets

Sponsor

Daiichi Sankyo